Genscript Biotech Corporation Total Liabilities

Latest as of December 2025: €888.59 Million EUR ≈ $1.04 Billion USD

Genscript Biotech Corporation total liabilities. Based on the latest financial reports, Genscript Biotech Corporation (G51) has total liabilities worth €888.59 Million EUR (≈ $1.04 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check G51 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Genscript Biotech Corporation (2016–2025)

Total liabilities of Genscript Biotech Corporation from 2016 to 2025. This chart illustrates how Genscript Biotech Corporation's total liabilities have evolved over time, based on quarterly financial data.

Genscript Biotech Corporation Competitors by Total Liabilities

The table below lists competitors of Genscript Biotech Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Jason Furniture(Hangzhou) SHG:603816	China	CN¥8.87 Billion
National Storage Affiliates Trust NYSE:NSA	USA	$3.56 Billion
Sino-American Silicon Products TWO:5483	Taiwan	NT$147.77 Billion
Impinj Inc NASDAQ:PI	USA	$335.95 Million
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	China	CN¥2.56 Billion
Suzhou Everbright Photonics Co. Ltd. A SHG:688048	China	CN¥320.36 Million
Skeena Resources Ltd TO:SKE	Canada	CA$951.63 Million
Jiangsu Changshu Rural Commercial Bank Co Ltd SHG:601128	China	CN¥384.66 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Genscript Biotech Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see G51 total assets.

Liquidity & Leverage Metrics

Genscript Biotech Corporation Total Liabilities Ratios Explained

Genscript Biotech Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genscript Biotech Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genscript Biotech Corporation (2016–2025)

The table below shows the annual total liabilities of Genscript Biotech Corporation from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€888.59 Million ≈ $1.04 Billion	-6.95%
2024-12-31	€954.91 Million ≈ $1.12 Billion	-28.89%
2023-12-31	€1.34 Billion ≈ $1.57 Billion	+13.45%
2022-12-31	€1.18 Billion ≈ $1.38 Billion	+3.85%
2021-12-31	€1.14 Billion ≈ $1.33 Billion	+80.40%
2020-12-31	€631.82 Million ≈ $738.66 Million	+22.18%
2019-12-31	€517.11 Million ≈ $604.56 Million	+22.05%
2018-12-31	€423.68 Million ≈ $495.32 Million	+53.54%
2017-12-31	€275.94 Million ≈ $322.61 Million	+556.84%
2016-12-31	€42.01 Million ≈ $49.12 Million	--

About Genscript Biotech Corporation

F:G51 Germany Biotechnology

Market Cap

$10.11 Billion

€8.65 Billion EUR

Market Cap Rank

#4429 Global

#776 in Germany

Share Price

€3.96

Change (1 day)

-7.04%

52-Week Range

€1.14 - €5.45

All Time High

€5.45